Public Company News

Wiwynn Launches Next-Gen Edge Servers with Extraordinary Performance and Efficiency in a Short-depth Form Factor

TAIPEI, Dec. 19, 2023 /PRNewswire/ -- Wiwynn (TWSE: 6669), an innovative cloud IT infrastructure provider for data centers, today announced to refresh its edge server line, Wiwynn®ES100G2 and ES200G2

2023-12-20 01:30 2721

NWTN Collaborates with Abu Dhabi Islamic Bank for Innovative Auto Financing Solutions

DUBAI, UAE, Dec. 19, 2023 /PRNewswire/ -- NWTN Inc. (Nasdaq: NWTN), an eco-conscious mobility technology company bringing passenger-centric green premium mobility solutions to the world ("NWTN" or the "Company"), is proud to announce a collaboration with Abu Dhabi Islamic Bank PJSC ("ADIB"). NWTN...

2023-12-19 21:40 5440

Jayud Announces New Air Charter Service Agreement with JD Airlines

New Charter Service from Shenzhen to Clark, Philippines, with Over 100 Round Trips Planned to Boost Cargo Capacity and Trade Relations SHENZHEN, China, Dec. 19, 2023 /PRNewswire/ -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solutio...

2023-12-19 21:00 5216

CHEERS Video Announces Product Upgrade and Rebrands as CHEERS Lifestyle Architect

BEIJING, Dec. 19, 2023 /PRNewswire/ -- Cheer Holding, Inc. (NASDAQ: CHR) ("Cheer Holding" or the "Company"), a leading provider of next-generation mobile internet infrastructure and platform services, is pleased to announce today a comprehensive upgrade to its CHEERS Video platform (the "platform...

2023-12-19 21:00 3125

Greenland Technologies Schedules 2023 Annual Meeting of Shareholders

EAST WINDSOR, N.J., Dec. 19, 2023 /PRNewswire/ -- Greenland Technologies Holding Corporation (Nasdaq: GTEC) ("Greenland" or the "Company"), a technology developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling machineries and vehicles, today announce...

2023-12-19 21:00 4910

New Drug Application of Mabwell's 8MW0511 for Injection Accepted by NMPA

SHANGHAI, Dec. 19, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that the new drug application of its recombinant (yeast-secreted) human serum albumin-human granulocyte colony-stimulating factor (I) fusion protein for injec...

2023-12-19 20:00 2245

INFOBIRD CO., LTD ANNOUNCES NEW BUSINESS COOPERATION IN INFORMATION TECHNOLOGY SYSTEM SOFTWARE DEVELOPMENT

HONG KONG, Dec. 18, 2023 /PRNewswire/ -- Infobird Co., Ltd (NASDAQ: IFBD) ("Infobird" or the "Company"), a software-as-a-service provider of AI-powered customer engagement solutions inChina, today announced that a new business cooperation in software development of information technology system h...

2023-12-19 06:00 5039

Dexter Studios, a Korean VFX company, presents an iconic VFX visual again on a global stage through 'YuYu Hakusho' as Netflix Original series

* Dexter Studios has added its global portfolio with 'YuYu Hakusho' in Netflix original series by diversifying the artwork concept of comic book characters being in real life * Emphasizing the genre characteristics of action, occult, and fantasies while trying to making it feel real about mag...

2023-12-18 21:00 2996

51Talk Online Education Group Announces Third Quarter 2023 Results

SINGAPORE, Dec. 18, 2023 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the third quarter endedSeptember 30, 2023. Third Quarter 2023 ...

2023-12-18 20:00 5065

Neuren Phase 2 trial shows significant improvements in Phelan-McDermid syndrome

Highlights:  * Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures   * Improvements were consistently seen across clinically important aspects of Phelan-McDermid syndrome, including communication, behaviour, cognition/learning and socialis...

2023-12-18 19:00 2023

GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)

YOGIN, South Korea, Dec. 17, 2023 /PRNewswire/ -- GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA) has approved ALYGLO (immune globulin intravenous, human-stwk) 10% Liquid, formerly referred to as "GC5107," for the treatment of adult patients aged 17...

2023-12-18 09:49 2594

Caliway Closes Oversubscribed Capital Raise and Secures Over $100M to Advance CBL-514 Pivotal Phase 3 Study in Subcutaneous Fat Reduction

TAIPEI, Dec. 16, 2023 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announced that it has closed an oversubscribed capital raise, securing over$100M by issuing 8 million new shares. The new funding will enable Caliway to advance the clinical development of its lead pipeline CBL-514, a sma...

2023-12-16 15:47 2989

Scienjoy Holding Corporation Reports Nine months ended September 30, 2023 Unaudited Financial Results

BEIJING, Dec. 15, 2023 /PRNewswire/ -- Scienjoy Holding Corporation ("Scienjoy", the "Company", or "we") (NASDAQ: SJ), an interactive entertainment leader in the Chinese market, today announced its unaudited financial results for the nine months endedSeptember 30, 2023. Nine Months 2023 Operatin...

2023-12-16 05:30 7130

Lufax Announces Receipt of Notice Regarding NYSE Continued Listing Standards and Effectiveness of its ADS Ratio Change

SHANGHAI, Dec. 15, 2023 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners inChina, today announced that it received a letter from the New York Stock Exchange (the "NYSE") datedNovember 30, 2023, n...

2023-12-16 05:30 7031

Appointment of New Independent Director

NEW YORK, Dec. 15, 2023 /PRNewswire/ -- Fresh2 Group Ltd. (NASDAQ: FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced the appointment ofZhijun (Michael) Liang, as an independent director of the Company,...

2023-12-16 05:01 3171

World's First and Largest Tower Crane Receives Recognition from 11 Industry Experts in Technical Appraisal

XUZHOU, China, Dec. 15, 2023 /PRNewswire/ -- The XGT15000-600S, the world's largest tower crane with the biggest double-boom parallel combination that is jointly developed by XCMG Machinery (SHE: 000425, "XCMG") and China Railway Major Bridge Engineering Co., Ltd. ("MBEC"), has recently been reco...

2023-12-16 01:46 5222

RING IN THE HOLIDAYS WITH PARAGON: THE OVERPRIME'S SECOND PLAYSTATION 5 CLOSED BETA TEST

LOS ANGELES, Dec. 15, 2023 /PRNewswire/ -- Netmarble, a leading developer and publisher of high-quality video games, announces the start of the second Closed Beta Test (CBT) forPARAGON: THE OVERPRIME on PlayStation 5. The CBT starts today throughJanuary 8 in the United States, Europe, and Russia....

2023-12-16 01:00 3891

Lixiang Education Announces Plan to Implement ADS Ratio Change

LISHUI, China, Dec. 15, 2023 /PRNewswire/ -- Lixiang Education Holding Co., Ltd. (the "Company" or NASDAQ: LXEH), a prestigious private education service provider inChina, today announced that it plans to change the ratio of its American depositary shares ("ADSs") to its ordinary shares (the "ADS...

2023-12-15 22:15 5956

KFC China Celebrates the Opening of its 10,000th Store

-       Milestone Store Opening Underscores KFC's Continued Success as the Leading Restaurant Brand inChina -       KFC China's Ambitious Growth Trajectory: Targeting Over Half of China's Population by 2026 SHANGHAI, Dec. 15, 2023 /PRNewswire/ -- Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9...

2023-12-15 22:00 7771

Akeso Published Results from CD47 Antibody Ligufalimab in Combination with Azacitidine for Newly Diagnosed Higher-Risk Myelodysplastic Syndrome and Treatment-naïve Acute Myeloid Leukemia at ASH 2023

HONG KONG, Dec. 15, 2023 /PRNewswire/ -- Akeso published two phase Ib clinical results of its innovative CD47 monoclonal antibody ligufalimab (AK117) in combination with azacitidine in patients with newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS) and treatment-naïve acute myeloid le...

2023-12-15 21:00 2851
1 ... 356357358359360361362 ... 766